---
title: "Zhejiang Sunflower Great Health Co., Ltd. (300111.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300111.SZ.md"
symbol: "300111.SZ"
name: "Zhejiang Sunflower Great Health Co., Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-20T05:31:42.143Z"
locales:
  - [en](https://longbridge.com/en/quote/300111.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300111.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300111.SZ.md)
---

# Zhejiang Sunflower Great Health Co., Ltd. (300111.SZ)

## Company Overview

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis; and azithromycin dispersible tablets and injections for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis and skin and soft tissue infection. The company also provides roxithromycin capsules to treat pharyngitis and tonsillitis caused by Streptococcus pyogenes, sinusitis, otitis media, acute bronchitis, acute exacerbation, as well as urethritis, cervicitis, and skin and soft tissue infection.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.sunowe.com](https://www.sunowe.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.57)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 133 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -20.40% |  |
| Net Profit YoY | -232.52% |  |
| P/B Ratio | 7.34 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4974399887.58 |  |
| Revenue | 254160079.95 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.39% | D |
| Profit Margin | -3.73% | D |
| Gross Margin | 24.24% | C |
| Revenue YoY | -20.40% | E |
| Net Profit YoY | -232.52% | E |
| Total Assets YoY | -1.98% | D |
| Net Assets YoY | -0.98% | D |
| Cash Flow Margin | 353.56% | A |
| OCF YoY | -20.40% | E |
| Turnover | 0.26 | D |
| Gearing Ratio | 15.83% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Zhejiang Sunflower Great Health Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-20.40%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-232.52%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "7.34",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4974399887.58",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "254160079.95",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.39%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-3.73%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "24.24%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-20.40%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-232.52%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.98%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.98%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "353.56%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-20.40%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "15.83%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -524.74 | 218/215 | 1427.47 | 890.14 | 637.72 |
| PB | 7.34 | 202/215 | 13.37 | 8.35 | 6.75 |
| PS (TTM) | 19.57 | 208/215 | 30.34 | 19.46 | 14.53 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300111.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300111.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300111.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300111.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**